117 related articles for article (PubMed ID: 7855615)
1. Multiple drug resistance: biologic basis and clinical significance in renal-cell carcinoma.
Chapman AE; Goldstein LJ
Semin Oncol; 1995 Feb; 22(1):17-28. PubMed ID: 7855615
[No Abstract] [Full Text] [Related]
2. The multidrug resistance gene in renal cell carcinoma.
Klein EA
Semin Urol; 1989 Nov; 7(4):207-14. PubMed ID: 2575783
[No Abstract] [Full Text] [Related]
3. Chemotherapy for renal cell carcinoma.
Amato RJ
Semin Oncol; 2000 Apr; 27(2):177-86. PubMed ID: 10768596
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for advanced renal-cell carcinoma: 1983-1993.
Yagoda A; Abi-Rached B; Petrylak D
Semin Oncol; 1995 Feb; 22(1):42-60. PubMed ID: 7855619
[No Abstract] [Full Text] [Related]
5. Chemotherapy for renal cell carcinoma.
Hartmann JT; Bokemeyer C
Anticancer Res; 1999; 19(2C):1541-3. PubMed ID: 10365141
[TBL] [Abstract][Full Text] [Related]
6. Advances in chemotherapy for renal cell carcinoma.
Huben RP
Semin Urol; 1992 Feb; 10(1):16-22. PubMed ID: 1565899
[No Abstract] [Full Text] [Related]
7. Connexin 32 potentiates vinblastine-induced cytotoxicity in renal cell carcinoma cells.
Sato H; Senba H; Virgona N; Fukumoto K; Ishida T; Hagiwara H; Negishi E; Ueno K; Yamasaki H; Yano T
Mol Carcinog; 2007 Mar; 46(3):215-24. PubMed ID: 17186540
[TBL] [Abstract][Full Text] [Related]
8. [Chemotherapy of renal cell carcinoma: experimental study and clinical effect].
Kanda H; Matsuura T; Akiyama T; Kurita T
Hinyokika Kiyo; 1988 Nov; 34(11):1879-84. PubMed ID: 3242362
[TBL] [Abstract][Full Text] [Related]
9. [Circumvention of the multidrug-resistance in renal cancer by bisbenzylisoquinoline].
Kakehi Y; Hashimura T; Yoshida O; Segawa T; Kanematsu A
Hinyokika Kiyo; 1993 Dec; 39(12):1227-32. PubMed ID: 8285174
[TBL] [Abstract][Full Text] [Related]
10. Phase II cytotoxic chemotherapy trials in renal cell carcinoma: 1983-1988.
Yagoda A
Prog Clin Biol Res; 1990; 350():227-41. PubMed ID: 2201045
[No Abstract] [Full Text] [Related]
11. Targeted for destruction: the molecular basis for development of novel therapeutic strategies in renal cell cancer.
Srinivasan R; Linehan WM
J Clin Oncol; 2005 Jan; 23(3):410-2. PubMed ID: 15572728
[No Abstract] [Full Text] [Related]
12. [Current status of chemotherapy for renal cell carcinoma].
Kato T; Sato K
Gan To Kagaku Ryoho; 1994 Jan; 21(1):23-8. PubMed ID: 8291912
[TBL] [Abstract][Full Text] [Related]
13. [Intraarterial chemotherapy for metastatic renal cell carcinomas: combination with MDR-overcoming agents].
Kakehi Y; Yoshida O; Segawa T; Kanematsu A; Hiura M; Shichiri Y; Arai Y
Hinyokika Kiyo; 1994 Oct; 40(10):925-9. PubMed ID: 7992710
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic chemotherapy for advanced renal cell carcinoma.
Yagoda A; Petrylak D; Thompson S
Urol Clin North Am; 1993 May; 20(2):303-21. PubMed ID: 8493752
[TBL] [Abstract][Full Text] [Related]
15. Will the dark sky over advanced renal cell carcinoma soon become brighter?
D'Hondt V; Gil T; Lalami Y; Piccart M; Awada A
Eur J Cancer; 2005 Jun; 41(9):1246-53. PubMed ID: 15939260
[TBL] [Abstract][Full Text] [Related]
16. Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B study.
Samuels BL; Hollis DR; Rosner GL; Trump DL; Shapiro CL; Vogelzang NJ; Schilsky RL
Clin Cancer Res; 1997 Nov; 3(11):1977-84. PubMed ID: 9815587
[TBL] [Abstract][Full Text] [Related]
17. Interview with professor Per-Anders Abrahamson: angiogenesis and renal cell carcinoma.
Abrahamson PA
Eur Urol; 2006 Sep; 50(3):609-11. PubMed ID: 16824676
[No Abstract] [Full Text] [Related]
18. Association of mdr1 gene expression with other prognostic factors and clinical outcome in human breast cancer.
Punyammalee B; Manoromana S; Purisa W; Chariyalertsak S; Rerkamnuaychok B
J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S162-73. PubMed ID: 9347665
[TBL] [Abstract][Full Text] [Related]
19. Altered expression of beta 1 integrins in renal carcinoma cell lines exposed to vinblastine.
Meyer N; Duensing S; Anastassiou G; Brevis Nunez F; Grosse J; Ganser A; Atzpodien J
Anticancer Res; 1999; 19(2C):1509-12. PubMed ID: 10365134
[TBL] [Abstract][Full Text] [Related]
20. Temsirolimus for advanced renal-cell carcinoma.
Ferretti G
N Engl J Med; 2007 Sep; 357(10):1050; author reply 1050-1. PubMed ID: 17823993
[No Abstract] [Full Text] [Related]
[Next] [New Search]
